PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China. huke-rmhospital@163.com.\', \'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China.\', \'Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China. hlli@ecust.edu.cn.\', \'State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China. xuke03@whu.edu.cn.\', \'State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, 430072, China. klan@whu.edu.cn.\', \'Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, 430072, China. klan@whu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12250-020-00258-7
?:doi
?:hasPublicationType
?:journal
  • Virologica Sinica
is ?:pmid of
?:pmid
?:pmid
  • 32696396
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.737
?:rankingScore_hIndex
  • 17
is ?:relation_isRelatedTo_publication of
?:title
  • A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32696396>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32696396>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all